Prevounce Remote Patient Monitoring helps providers systematically improve their management of some of the most prevalent and dangerous disease states affecting populations in the United States.
Hypertension (i.e., high blood pressure) affects nearly half of U.S. adults and most do not have it under control. When hypertension is managed poorly or not managed at all, the likelihood of heart disease, stroke, and death increases. One of the most significant challenges associated with hypertension management is that high blood pressure typically presents without any obvious signs or symptoms that something is wrong with a patient. The only means of identifying whether patients have hypertension is through measuring blood pressure.
With remote monitoring of hypertension via the Prevounce system, providers gain the ability to receive and review blood pressure data on a consistent basis. This permits providers to better identify potentially concerning trends and developments and make more timely recommendations and modifications to a patient’s care plan, including changes to exercise, diet, and medication regimen. Such ongoing interactions and revisions, when necessary, more effectively engage patients in their care and better supports heart-healthy living. The American Heart Association has cited research showing that remote patient monitoring can improve hypertension management and reduce blood pressure compared to typical care and patient self-monitoring alone.
Hypertension (i.e., high blood pressure) affects nearly half of U.S. adults and most do not have it under control. When hypertension is managed poorly or not managed at all, the likelihood of heart disease, stroke, and death increases. One of the most significant challenges associated with hypertension management is that high blood pressure typically presents without any obvious signs or symptoms that something is wrong with a patient. The only means of identifying whether patients have hypertension is through measuring blood pressure.
With remote monitoring of hypertension via the Prevounce system, providers gain the ability to receive and review blood pressure data on a consistent basis. This permits providers to better identify potentially concerning trends and developments and make more timely recommendations and modifications to a patient’s care plan, including changes to exercise, diet, and medication regimen. Such ongoing interactions and revisions, when necessary, more effectively engage patients in their care and better supports heart-healthy living. The American Heart Association has cited research showing that remote patient monitoring can improve hypertension management and reduce blood pressure compared to typical care and patient self-monitoring alone.
Despite the significant attention it has received in recent years, obesity remains one of the most significant health problems for Americans. More than 42% of the adult population is considered obese as per 2017–2018 data — a figure that’s up from about 31% as of 1999–2000. Obesity directly contributes to poor mental health outcomes and overall reduced quality of life. It’s associated with leading causes of death, including heart disease, diabetes, stroke, and some cancers. Obesity has also been shown to increase the risk of severe illness from COVID-19. Models estimate that of the more than 900,000 U.S. adult COVID-19 hospitalizations that occurred between the beginning of the pandemic and mid-November 2020, about 30% were attributed to obesity.
Where many efforts to get obesity under control and reverse it have failed, remote patient monitoring with Prevounce succeeds. When providers leverage RPM, they are in a better position to deliver more timely and targeted advice for lifestyle and medication regimen changes that can help stabilize or reduce weight while also identifying concerning trends early and implementing personalized solutions. Remote patient monitoring has been proven to achieve behavior changes necessary to get obesity under better control. Strengthened obesity management can decrease dangerous health risks, improve cholesterol levels, address sleep apnea, and save patients and the healthcare system significant money, among many benefits.
Despite the significant attention it has received in recent years, obesity remains one of the most significant health problems for Americans. More than 42% of the adult population is considered obese as per 2017–2018 data — a figure that’s up from about 31% as of 1999–2000. Obesity directly contributes to poor mental health outcomes and overall reduced quality of life. It’s associated with leading causes of death, including heart disease, diabetes, stroke, and some cancers. Obesity has also been shown to increase the risk of severe illness from COVID-19. Models estimate that of the more than 900,000 U.S. adult COVID-19 hospitalizations that occurred between the beginning of the pandemic and mid-November 2020, about 30% were attributed to obesity.
Where many efforts to get obesity under control and reverse it have failed, remote patient monitoring with Prevounce succeeds. When providers leverage RPM, they are in a better position to deliver more timely and targeted advice for lifestyle and medication regimen changes that can help stabilize or reduce weight while also identifying concerning trends early and implementing personalized solutions. Remote patient monitoring has been proven to achieve behavior changes necessary to get obesity under better control. Strengthened obesity management can decrease dangerous health risks, improve cholesterol levels, address sleep apnea, and save patients and the healthcare system significant money, among many benefits.
Just how bad is heart failure in the United States? Statistics show that more than 6 million adults have heart failure, and it was mentioned in close to 400,000 (~13%) death certificates in 2018. These figures are expected to get much worse. The American Heart Association projects that the number of people diagnosed with heart failure will surpass 8 million people by 2030. Congestive heart failure (CHF), a chronic progressive condition, can lead to decreased quality of life and death.
While not all of the conditions that contribute to heart failure can be reversed, effective, timely treatment can make a significant difference in a patient’s quality of life by helping prevent heart failure and reducing hospitalizations. With Prevounce remote patient monitoring, providers and their CHF patients gain much greater control over the disease. Consider that steady or rapid gain in daily weight is a possible indicator that a patient is retaining fluid, which is a common symptom of heart failure. An increase of 2-3 pounds over just 24 hours or 5 pounds in a single week may indicate heart failure. It’s easy for such weight gain due to fluid retention to be missed if weight is not regularly monitored. In fact, patients can gain 10 pounds of “extra” fluid weight without ever feeling unwell or experiencing swelling.
The Prevounce RPM system allows providers to identify a sudden or steady increase in weight. They receive alerts when cardiac decompensation occurs, supporting faster action that will help improve the patient’s condition and decrease the need for urgent or emergent care. Ongoing weight monitoring is considered one of the foundations for effective congestive heart failure management, with the American Heart Association stating that weight gain is often the initial indication of worsening CHF.
Just how bad is heart failure in the United States? Statistics show that more than 6 million adults have heart failure, and it was mentioned in close to 400,000 (~13%) death certificates in 2018. These figures are expected to get much worse. The American Heart Association projects that the number of people diagnosed with heart failure will surpass 8 million people by 2030. Congestive heart failure (CHF), a chronic progressive condition, can lead to decreased quality of life and death.
While not all of the conditions that contribute to heart failure can be reversed, effective, timely treatment can make a significant difference in a patient’s quality of life by helping prevent heart failure and reducing hospitalizations. With Prevounce remote patient monitoring, providers and their CHF patients gain much greater control over the disease. Consider that steady or rapid gain in daily weight is a possible indicator that a patient is retaining fluid, which is a common symptom of heart failure. An increase of 2-3 pounds over just 24 hours or 5 pounds in a single week may indicate heart failure. It’s easy for such weight gain due to fluid retention to be missed if weight is not regularly monitored. In fact, patients can gain 10 pounds of “extra” fluid weight without ever feeling unwell or experiencing swelling.
The Prevounce RPM system allows providers to identify a sudden or steady increase in weight. They receive alerts when cardiac decompensation occurs, supporting faster action that will help improve the patient’s condition and decrease the need for urgent or emergent care. Ongoing weight monitoring is considered one of the foundations for effective congestive heart failure management, with the American Heart Association stating that weight gain is often the initial indication of worsening CHF.
Chronic lower respiratory disease, which is primarily chronic obstructive pulmonary disease (COPD), is the third leading cause of death by disease in the United States. It’s been diagnosed in more than 16 million Americans and millions more are likely unaware that they have COPD. While it is progressive disease, COPD is treatable. Proper, timely management of COPD allows patients to get their symptoms under better control, reduce the risk of associated conditions, and ultimately achieve enhanced quality of life.
Remote patient monitoring is quickly becoming the chronic obstructive pulmonary disease management tool of choice for providers and patients, with appreciation for and usage of RPM greatly buoyed by the pandemic. After providers collaborate with COPD patients on a plan that typically combines medications, oxygen therapy, rehabilitation, and support, RPM then gives providers the ability to perform timely, effective oversight of the disease. By leveraging an RPM platform like Prevounce, providers gain access to critical peak flow measurements that can indicate the likelihood of or increased potential for an acute exacerbation. With this ongoing data, providers can also assess whether treatment is working as planned. Along with peak expiratory flow, parameters often measured with peak flow include FVC, FEV1, FEV1/FVC, FEF2575, FEV6, VEXT, DTPEF, FEF75, FET, FEF25, FEF50, FIVC, FIV1, PIF, FEV3, FEV05, FEV075, and FEV2. With access to this patient data comes improvements in decision support and patient adherence to guidance and recommendations for COPD and other lung diseases, such as asthma and bronchiectasis. Evidence that supports the usage of RPM for COPD management is building (e.g., Medical & Biological Engineering & Computing article, JMIR Cardio analysis).
Chronic lower respiratory disease, which is primarily chronic obstructive pulmonary disease (COPD), is the third leading cause of death by disease in the United States. It’s been diagnosed in more than 16 million Americans and millions more are likely unaware that they have COPD. While it is progressive disease, COPD is treatable. Proper, timely management of COPD allows patients to get their symptoms under better control, reduce the risk of associated conditions, and ultimately achieve enhanced quality of life.
Remote patient monitoring is quickly becoming the chronic obstructive pulmonary disease management tool of choice for providers and patients, with appreciation for and usage of RPM greatly buoyed by the pandemic. After providers collaborate with COPD patients on a plan that typically combines medications, oxygen therapy, rehabilitation, and support, RPM then gives providers the ability to perform timely, effective oversight of the disease. By leveraging an RPM platform like Prevounce, providers gain access to critical peak flow measurements that can indicate the likelihood of or increased potential for an acute exacerbation. With this ongoing data, providers can also assess whether treatment is working as planned. Along with peak expiratory flow, parameters often measured with peak flow include FVC, FEV1, FEV1/FVC, FEF2575, FEV6, VEXT, DTPEF, FEF75, FET, FEF25, FEF50, FIVC, FIV1, PIF, FEV3, FEV05, FEV075, and FEV2. With access to this patient data comes improvements in decision support and patient adherence to guidance and recommendations for COPD and other lung diseases, such as asthma and bronchiectasis. Evidence that supports the usage of RPM for COPD management is building (e.g., Medical & Biological Engineering & Computing article, JMIR Cardio analysis).
Data shows that more than 1 out of every 10 people in the United States has diabetes. That’s more than 34 million people. Furthermore, a staggering 88 million people 18 years or older in the United States have prediabetes, which is more than one-third of the adult population. Like many other chronic diseases, diabetes is incurable. But like many chronic diseases, remote patient monitoring can help greatly reduce the impact of diabetes on a patient’s life. One of the essential steps to diabetes management is glucose monitoring, either continuous glucose monitoring (CGM) or non-continuous glucose monitoring, depending upon the type of diabetes.
Remote glucose monitoring, when used with the Prevounce remote patient monitoring system, informs providers when patients’ blood sugar levels experience noteworthy increases or decreases. When providers have access to blood sugar level data and can identify when a concerning change occurs, they can make timely adjustments to a patient’s diabetes management and treatment plan that help keep the disease under control. Research has shown that remote patient monitoring is effective in controlling HbA1c levels in those with type 2 diabetes. Additional research has shown that elevated levels of patient activation and engagement with RPM technology — benefits of using the Prevounce system — is associated with better glycemic control outcomes.
Data shows that more than 1 out of every 10 people in the United States has diabetes. That’s more than 34 million people. Furthermore, a staggering 88 million people 18 years or older in the United States have prediabetes, which is more than one-third of the adult population. Like many other chronic diseases, diabetes is incurable. But like many chronic diseases, remote patient monitoring can help greatly reduce the impact of diabetes on a patient’s life. One of the essential steps to diabetes management is glucose monitoring, either continuous glucose monitoring (CGM) or non-continuous glucose monitoring, depending upon the type of diabetes.
Remote glucose monitoring, when used with the Prevounce remote patient monitoring system, informs providers when patients’ blood sugar levels experience noteworthy increases or decreases. When providers have access to blood sugar level data and can identify when a concerning change occurs, they can make timely adjustments to a patient’s diabetes management and treatment plan that help keep the disease under control. Research has shown that remote patient monitoring is effective in controlling HbA1c levels in those with type 2 diabetes. Additional research has shown that elevated levels of patient activation and engagement with RPM technology — benefits of using the Prevounce system — is associated with better glycemic control outcomes.
Sustained compliance. Credit for chronic care services. Full reimbursement. Easy eligibility. Streamlined annual wellness visits. Simple remote patient monitoring. Prevounce makes all this and more possible. Schedule a live demo and let us show you how.
Prevounce creates wellness that works for everyone, with practice-specific, software-based programs that make preventive care, chronic care management, and remote patient monitoring easier to prep for, perform, document, and bill.
© Copyright 2023 Prevounce - All Rights Reserved